Cosmos Pharmaceutical Corp operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cosmos Pharmaceutical Corp with three other
companies in this sector in Japan:
Sugi Holdings Company Limited
sales of 457.05 billion Japanese Yen [US$4.02 billion]
of which 100%
was Drug Compounding Business),
Sundrug Co Ltd
(564.22 billion Japanese Yen [US$4.97 billion]
of which 65%
was Drugstore Business), and
Matsumotokiyoshi Holdings Company Limited
(558.88 billion Japanese Yen [US$4.92 billion]
of which 63%
was Matsumotokiyoshi Retail).
Cosmos Pharmaceutical Corp reported sales of ¥558.00 billion (US$4.91 billion)
May of 2018.
increase of 11.0%
versus 2017, when the company's sales were ¥502.73 billion.
Sales at Cosmos Pharmaceutical Corp have increased during each of the previous five years
(and since 2013, sales have increased a total of 69%).